StockWatch
·

TIMKEN INDIA LTD. Q2 FY27 Results

TIMKENQ2 FY27 Results
Filing
Result:Very Good· Market: Flat#Margin expansion

Outlook: Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue969.304.3%25.4%
Total Income977.364.0%24.9%
Expenditure821.124.1%24.0%
PBT156.243.9%29.5%
Net Profit116.060.8%29.7%
OPM18.37%0.17pp0.46pp
NPM11.88%0.38pp0.45pp
EPS15.430.8%29.8%
View full financials

Industrials standout with revenue up 25.4% YoY and adjusted PAT up 29.7%, driven by core business with OPM expanding to 18.4% and NPM to 11.9% rather than one-offs.

TIMKEN INDIA LTD. · Q2 FY27 · THE VERDICT

Record growth masks sequential profit fade and rising cost pressure

Q2 revenue jumped 25.4% YoY and profit 29.7%, corroborating the upswing narrative. But quarter-on-quarter, revenue growth slowed to 2.8% and profit actually fell 3.0%—a signal that cost inflation is outpacing pricing power. The real test begins now.

03 Nov 2026 · 6 min read
YoY Revenue growth

25.4%

₹969.3 Cr

YoY PAT growth

29.9%

₹116.1 Cr

QoQ Revenue growth

2.8%

Management claimed 4.3%

QoQ PAT decline

-3.0%

Q1 ₹119.4 Cr vs Q2 ₹116.1 Cr

The headline reads like a blowout: Timken posted its best YoY growth in years, +25.4% revenue and +29.7% profit, tracking management's bullish narrative on exports, industrial segment accretion, and capacity expansion. On the surface, it works. But the real tension sits in the quarter-on-quarter numbers. Despite a 2.8% sequential revenue bump—short of management's stated 4.3%—profit actually declined 3.0%. That reversal, with input costs rising across carbides (up 200%), steel, and gas, signals one hard truth: margin expansion has hit a wall.

The margin squeeze: YoY masks QoQ decay

Operating profit margin improved 50 basis points YoY to 18.4%, but the quarterly trajectory tells a different story. Q1 FY27 must have posted a higher OPM to yield H1 OPM below Q2's 18.4%. More important, the MD on the call was candid: "Cost is going up and will still go up…nobody can absorb it. Industry cannot absorb it." Yet customer pass-through remains vague. The company is "working on it continuously," but the timing and magnitude are unknown. Meanwhile, QoQ profit declined despite revenue growth—a textbook sign that price increases are not yet flowing through, or that unfavourable mix (rail weakness at just 16% of revenue) is dampening realized pricing.

Q2 FY27 growth rates (YoY vs QoQ), %
-6.926.5920.1133.6225.4Revenue YoY29.7PAT YoY2.8Revenue QoQ-3PAT QoQ
The YoY narrative is strong, but sequential momentum is collapsing. Margin pressure is the culprit.

Management's claims vs. what holds up

Earnings call assertions ranked by credibility

Strong double-digit revenue and profit growth

What the numbers show

+25.4% revenue, +29.7% PAT YoY

Verdict

Supported

4.3% revenue growth over Q1

What the numbers show

Actual QoQ revenue 2.8%

Verdict

Overstated (50% miss)

Bharuch targeting 70% spherical roller bearing utilization by Aug-Sep

What the numbers show

Bharuch at 60% SRB utilization as of Q2 call; target deferred to year-end

Verdict

Missed / Slipped ~3 months

Exports grew 60% YoY, driving segment momentum

What the numbers show

Q2 exports ₹262.7 Cr (27% of total), +60% YoY confirmed in Q&A

Verdict

Supported

Rail segment recovering; tenders in full swing; 2–3 weeks to orders

What the numbers show

Rail only ₹156.7 Cr (16% of Q2), down-mix. Trial runs Nov–Dec; PPAPs after.

Verdict

Partial (recovery delayed to Q3–Q4)

Industry must absorb cost inflation; we will pass it through

What the numbers show

QoQ PAT -3% despite +2.8% revenue growth

Verdict

Unproven (pass-through not yet visible in realized margins)

What changed on this call

Timken's Q1 narrative was cautiously bullish on capacity expansion and exports. Q2 elevated three new headwinds into primary risk territory:

  • Cost inflation as structural near-term risk (not transient)

  • Bharuch utilization target slipped from Aug–Sep to year-end (3-month delay)

  • Rail segment weakness now explicitly flagged (16% of mix, tenders delayed)

  • Exports & industrial segment revealed as stand-out strength (+60% YoY exports, margin-accretive mix)

  • Capex guidance reaffirmed but not upgraded (8–10% of revenue; no multi-year growth acceleration target)

The bull-bear ledger

  • Revenue +25.4% YoY, profit +29.7% YoY (momentum corroborated)

  • Exports +60% YoY, 27% of revenue and accelerating (diversification away from auto, higher margin)

  • Industrial segment (SRB, CRB) margin-accretive; offsetting auto weakness

  • Bharuch ramp progressing (₹75 Cr Q2 vs ₹50 Cr Q1, +50% QoQ); capex pipeline real (rail ₹120 Cr, Bharuch ₹70 Cr, GGB ₹35–70 Cr)

  • QoQ PAT declined 3.0% despite 2.8% revenue growth (margin compression underway)

  • Cost headwinds "will still go up"; customer pass-through timing and magnitude unproven

  • Rail segment (16% of mix) delayed; recovery hinges on Nov–Dec trial runs and tender conversion

  • Bharuch at 60%, below 70% Aug–Sep target; customer MOC delays may persist

  • Capex execution risk across three fronts (Bharuch, rail, GGB); asset turn expectations untested

  • Export concentration: 27% of revenue, heavily North American rail & process industries; customer concentration unquantified

How the street is positioned

Timken trades at ₹3,020, down 37.3% from its all-time high of ₹4,817.9, but up 12.4% off its 52-week low. The stock sits above its 20-day moving average (₹2,907) but below both the 50-day (₹3,062) and 200-day (₹3,269), signalling a recovery attempt within a longer downtrend. RSI is neutral at 56.4—neither overbought nor oversold.

The ownership story is more telling. Foreign institutional investors have exited steadily: FII ownership fell from 9.44% in FY26 Q1 to 7.32% as of FY27 Q1, a loss of 212 basis points. In the same period, domestic institutions held steady around 30%, and promoters remained locked at 51.05%. No insider buying near the lows—a yellow flag. The FII exodus is the market's own verdict: even as Timken posts record YoY growth, institutions are trimming, likely spooked by the sequential margin decay and cost headwinds visible to any analyst reading the Q&A.

In short, the stock's 37% drawdown reflects the street's awareness that headline growth masks softening momentum. The FII exit confirms it. This is not a recovery play; it is a "prove the pricing power" play.

Risks, ranked by how much they should concern a holder

Critical risks ordered by severity and immediate materiality

Margin compression from unabsorbed cost inflation

HIGH

Carbides +200%, steel and gas rising. QoQ PAT already -3% despite revenue growth. MD acknowledged "industry cannot absorb it," yet pass-through timing and magnitude are unknown. If Q3 PAT continues to decline YoY while revenue grows, the cycle turns bear.

Bharuch utilization shortfall and capex ROI uncertainty

HIGH

Bharuch at 60% vs 70% target (Aug–Sep missed, deferred to year-end). ₹70 Cr capex underway; asset turn expectation (1–1.5x) untested. MOC delays on customer side may persist. If utilization stalls below 65%, payoff extends further and ROI disappoints.

Rail tenders conversion risk and segment mix headwind

MEDIUM-HIGH

Rail only 16% of Q2 revenue, weighed by delayed tenders. Trial runs Nov–Dec; PPAPs after. If orders don't materialize as expected, or convert at lower volumes, Q3–Q4 earnings will miss. Rail is a margin-accretive segment; weakness is a drag.

Capex execution across three fronts (INR 225+ Cr over 2 years)

MEDIUM

Bharuch ₹70 Cr, rail ₹120 Cr, GGB ₹35–70 Cr. Asset turns, payoff timelines, and synergies are untested. Execution delays or capex overruns would compress FY27–28 free cash flow and extend payback.

Export concentration and customer dependence

MEDIUM

Exports 27% of Q2 revenue, +60% YoY. Heavily weighted to North American rail and process industries (ZF, Flenders gearbox references). No customer concentration disclosed. A loss of a major OEM or tender setback would halve export growth.

Secular headwinds in auto segment (lower margin) and inventory destocking

MEDIUM

Auto segment (mobile non-rail, 21% of Q2) is lower-margin and faces EV transition headwinds. No inventory build/destocking commentary on the call; working capital risk if orders soften.

The debate

What to watch next

Three concrete things that resolve the debate by Q3 FY27
  • 1 · Rail plant trial runs (Nov–Dec 2026) and tender conversion

    Do trial runs proceed on schedule and convert to orders by Q3? If yes, rail revenue should jump to 18–20% of Q3 and lift segment margins. If delayed or orders miss, the bear case hardens.

  • 2 · Bharuch reaches 70% utilization target by Dec 2026

    Is the ramp (₹75 Cr Q2 → target ₹100+ Cr by Q3) real or slipping further? If 70% is hit on schedule, ROE on the ₹70 Cr capex is on track. If slipped, capex payoff extends and execution risk escalates.

  • 3 · QoQ operating profit stabilization or recovery in Q3 FY27

    If cost pass-through works, OPM should hold or expand despite continued input inflation. If QoQ OPM declines further (or PAT remains flat/negative), pricing power is unproven and margin compression is structural, not transient. This is the number that resolves the bull–bear debate.

Timken delivered a headline-grabbing quarter on YoY metrics, but the sequential profit decline amid rising costs signals that the cycle is already slowing. This is not a step-change or recovery. It is a steady industrial business facing near-term margin headwinds and execution risk on a large capex ramp. The FII exit at 212 basis points is the street's vote: growth is real, but pricing power is unproven.

The stock has fallen 37% from its all-time high and sits below key moving averages. It is not yet cheap—not until the margin story stabilizes. The number to track from here is QoQ operating profit in Q3 FY27 (due by Dec 2026). If it holds or expands despite input costs, the bull case re-entry point emerges. If it compresses further, margin cycle deepens and the 37% drawdown may be just the opening act of a longer unwind. Until pricing power is proven, the risk/reward favors the sidelines.

Informational and educational content only. Not investment advice.